CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
SinEcch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03944629
NCT03944629N/ACompleted

Efficacy of Arnica Montana in Reducing Postoperative Edema and Pain Following Third Molar Extraction

Tufts University·interventional·Posted May 9, 2019·Updated Jan 29, 2026

In Brief

A clinical study evaluating SinEcch and Placebo for Arnica and Third Molar Extraction. Completed, enrolled 53 participants across 1 site.

Detailed Summary

This study is a prospective, randomized, double-blinded, controlled, clinical trial that evaluates the efficacy of using high potency homeopathic Arnica montana (SinEcch™) during the perioperative period for decreasing swelling and pain after extraction of partial or full/complete bony impacted third molars. The study group will be comprised of subjects who will receive homeopathic Arnica montana (SinEcch™) for perioperative management of edema and pain. The control group will be comprised of subjects who will receive matching SinEcch™ placebo (sugar pill).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 9, 2019
Enrollment StartJan 26, 2018
Primary CompletionJun 14, 2022
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 7.1 years ago

Interventions

SinEcchdrug

The study group will be comprised of subjects who will receive homeopathic Arnica montana (SinEcch™) for perioperative management of edema and pain.

Placeboother

The control group will be comprised of subjects who will receive matching SinEcch™ placebo (sugar pill).